Chronic wound mitomycin-c-induced animal models
Andreas Ariawan(1*), Aditya Wicaksana(2), Aditya Rifqi Fauzi(3), Rosadi Seswandhana*(4)
(1) Division of Plastic and Reconstructive Surgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
(2) Division of Plastic and Reconstructive Surgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
(3) Division of Plastic and Reconstructive Surgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
(4) Division of Plastic and Reconstructive Surgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia
(*) Corresponding Author
Abstract
ABSTRACT
Chronic wound is a problem often encountered, especially in areas that do not have adequate health facilities. Some of the factors that caused the injury are mechanical, chemical, electrical, or heat. Chronic inflammation and bacterial infections are the two major factors that affect the process of wound chronicity. Mitomycin-C (MMC) is widely used as an intravenous, oral, and topical anti-cancer drug. MMC that is applied topically to a wound can cause cross-linking and decrease or stop the process of DNA transcription so that the wound will not develop the healing phase because MMC works as an inhibitor of fibroblast and proliferation that can inhibit wound healing. This study aimed to create animal models of chronic wound using topical MMC compared to those who given exposure of NaCl without topical MMC. This study used eight female Wistar rats aged 70 to 90 days, weighed between 300 to 350 grams. Wounds were made in the hip area with a diameter of approximately two centimeters. The subjects were divided into two groups. The first group, we compressed the wounds using sterile gauze moistened with MMC 0.5 mg/ml for 5 minutes and rinsed with a saline solution as much as 10 ml6. The second group was compressed using sterile gauze moistened with saline for 5 minutes. On day 3, 5, and 15 we observed the wound profile that was consist of diameter (as an indicator of wound healing), necrosis, and the consistency. The wounds that were compressed using MMC showed brownish-black, dry, thick chronic wounds and took longer to heal compared to those with NaCl. Application of MMC topically on the wound after day 15 showed an inhibition of wound healing process. The animal models showed a slower decrease of wound diameter, fewer scar tissue formation, and development of necrotic tissue.
Keywords
Full Text:
PDFReferences
- Wall IB, Moseley R, Baird DM, Kipling D, Giles P, Laffafian I, et al. Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J Invest Dermatol 2008; 128(10):2526-40. http://dx.doi.org/10.1038/jid.2008.114
- Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in chronic wounds. Int J Mol Sci 2016; 17(12):2085. http://dx.doi.org/10.3390/ijms17122085
- Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechaisms, signaling and translation. Sci Transl Med 2014; 6(265):265sr6. http://dx.doi.org/10.1126/scitranslmed.3009337.
- Paz MM, Zhang X, Lu J, Holmgren A. A new mechanism of action for the anticancer drug mitomycin C: menchanism-based inhibition of thioredoxin reductase. Chem Res Toxicol 2012; 25(7):1502-11. http://dx.doi.org/10.1021/tx3002065
- Snodgrass RG, Collier AC, Coon AE, Pritsos C. Mitomycin C inhibits ribosomal RNA. J Biol Chem 2010; 285(25): 19068-75. http://dx.doi.org/10.1074/jbc.M109.040477
- Ribeiro FA, Guaraldo L, Borges JP, Vianna MR, Eckley CA. Study of wound healing in rats treated with topical and injected mitomycin-C. Ann Otol Rhinol Laryngol 2008;17(10):786-90. http://dx.doi.org/10.1177/000348940811701015
- Krzyszczyk P, Schloss R, Palmer A, Berthiaume F. The role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes. Front Physiol 2018;9:419. http://dx.doi.org/10.3389/fphys.2018.00419
- Porter GT, Gadre SA, Calhoun KH. The effects of intradermal and topical mitomycin C on wound healing. OtolaryngolHead Neck Surg 2006;135(1):56-60. http://dx.doi.org/10.1016/j.otohns.2006.02.024
- Gonzalez ACO, Costa TF, Andrade ZA, Medrado ARAP. Wound healing – a literature review. An Bras Dermatol 2016; 91(5): 614-20. http://dx.doi.org/10.1590/abd1806-4841.2016474
- Shaw TJ and Martin P. Wound repair at a glance. J Cell Sci 2009; 122: 3209-13.
- Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008; 453:314-21.
- Gal P, Kilik R, Mokry M, Vidinsky B, Vasilenko T, Mozes S, et al. Simple method of open skin wound healing model in corticosteroid-treated and diabetic rats: standardization of semi-quantitative and quantitative histological assessments. Veterinarni Medicina 2008;53(12):652-9. http://dx.doi.org/10.17221/1973-VETMED
- Martin P, Nunan R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. British J Dermatol 2015;173(2):370-8. http://dx.doi.org/10.1111/bjd.13954
- Gray SD, Tritle N, Li W. The effect of mitomycin on extracellular matrix proteins in a rat wound model. Laryngoscope 2003;113(2):237-42. http://dx.doi.org/10.1097/00005537-200302000-00008
- Lampus HF, Kusmayadi DD, Nawas BA. The influence of topical mitomycin-C on total fibroblasts, epithelialization, and collagenization in anoplasty wound healing in Wistar rats. J Pediatr Surg 2015;50(8):1347-51. http://dx.doi.org/10.1016/j.jpedsurg.2015.03.059Su C, Sui T, Zhang X, Zhang H, Cao X. Effect of topical application of mitomycin-C on wound healing in a postlaminectomy rat model: an experimental study. Eur J Pharmacol 2012; 674(1):7-12. http://dx.doi.org/10.1016/j.ejphar.2011.10.028
- Su C, Sui T, Zhang X, Zhang H, Cao X. Effect of topical application of mitomycin-C on wound healing in a postlaminectomy rat model: an experimental study. Eur J Pharmacol 2012; 674(1):7-12. http://dx.doi.org/10.1016/j.ejphar.2011.10.028
DOI: https://doi.org/10.19106/JMedSci005002201803
Article Metrics
Abstract views : 1775 | views : 2012Copyright (c) 2018 Andreas Ariawan, Aditya Wicaksana, Aditya Rifqi Fauzi, Rosadi Seswandhana*
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.